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APPROPRIATE ICU UTILIZATION FOR BMT PATIENTS
Jenkins, T.L. Stanford University Hopsital, Stanford, CA.
Purpose: To develop criteria to ensure appropriate admission of
BMT patients to the ICU. In order to avoid inappropriate ICU
days, guidelines were developed and a process outlined to improve
communication between the BMT and ICU teams, and the teams
and the family. Background: Appropriate resource utilization is
critical with rising health care costs and the scarcity of ICU beds.
Guidelines were needed for the appropriate admission of BMT pa-
tients to the ICU.
Communication between medical teams was often fragmented.
Additionally family members often receive conflicting information
from the teams. Unclear communication makes it difficult for
patients and families to make educated decisions regarding care
options, which can result in over utilization of the ICU for non-
beneficial care. Procedure: Our BMT program had an increase
in ICU utilization, with ICU days increased from 3.3% in FY05
to 5.1% in FY06. Average BMT ICU LOS increased from 4.8
days to 11.7 days.
A multidisciplinary team met to discuss current issues, brain-
storm ideas and create guidelines based on current literature. The
following guidelines were developed:
- Guidelines for appropriate admission of BMT patients to the
ICU are based on review of recent literature and probability of
survival.
- Established daily rounds between BMT and ICU teams to discuss
patients in the ICU and enhance communication.
- The BMT and ICU team meet with the patient or family every 48
hours during ICU stay to clarify goals of care.
- BMT ICU monitoring tool developed to monitor adherence to
guidelines.
- All BMT patients sent to ICU are reviewed at the monthly BMT
meetings.
- Created a BMT Advanced Care Planning addendum to educate
patients and families and create a forum for discussion and goal
planning with their MD.
Results: To date, all but one of the 13 BMT patients transfered to
the ICU met the criteria. The BMT and ICU teams have rounded
daily and discussed the plan for all BMT patients in the ICU. In ad-
dition the teams have met with families every 3–4 days. As a result,
we have decreased BMT ICU days to 3.4% and the ICU average
LOS down to 8.1 days.
The project has resulted in guidelines for appropriate admissions
of BMT patients to the ICU. Appropriate utilization of ICU beds
for BMT patients results in better resource utilization and avoiding
futile care. The daily team rounds and family meetings team re-
sulted in clarity of information and communication to patients
and family, enabling families to make educated decisions.465
PRIORITY CONCERNS OF PATIENTS RECEIVING AUTOLOGOUS OR ALLO-
GENEIC STEM CELL TRANSPLANTS AT THE SEATTLE CANCER CARE AL-
LIANCE
Klein, C.1, Berry, D.L.1,2, Fann, J.1, Halpenny, B.2, Lober, W.2,
Wolpin, S.2, Bush, N.3. 1Seattle Cancer Care Alliance, Seattle, WA;
2University of Washington, Seattle, WA; 3Fred Hutchinson Cancer Re-
search Center, Seattle, WA.
Purpose: In a focused history, transplant clinicians may not ad-
dress the issues perceived to be most important to patients. Studies
indicate that while oncologists are attentive to adverse symptoms,
communication tends to be clinician-oriented with interruptions
and closed-ended questions. The use of touchscreen computers
by stem cell transplant (SCT) patients to report symptom and qual-
ity of life (QOL) measures has been investigated at the SCCA. The
purpose of this analysis was to identify priority concerns reported at
the time of nurse teaching (T1) and after transplant (T2), usinga self-report assessment program for cancer (ESRA-C). Methods:
228 SCT patients included in this analysis completed ESRA-C at
T1 and T2 before their clinic visits. The ESRA-C includes validated
questionnaires to assess symptoms and QOL and an open-ended
text field with the following instructions: ‘‘Please type in the two
most important concerns or issues that we should address first
with you and/or anything else you want to tell us about.’’ The results
were content analyzed by grouping the 139 allogeneic (allo) and 89
autologous (auto) patients and identifying concerns and symptom
categories and commonalities in the written text responses.
Results: Patient characteristics included 57% men and 77% with
post-secondary education. Free text entries were more frequent at
T1. Four common global concerns were reported at T1: financial,
survival, QOL, family/caregiver issues and one symptom, depres-
sion. The two areas of highest concern were 1) financial, greater
in the auto group (13.5% vs 3.5%); and 2) survival, more common
in the allo group (13.0% vs 7.9%). Eight of the common symptoms/
side effects were categorized: fatigue, complications of graft versus
host, diarrhea, nausea, appetite loss and infection. The symptoms,
as opposed to global concerns, were reported as priority concerns
most often at T2.Conclusions:Computerized assessment is a novel
way for patients to report a spectrum of symptoms and quality of life
status, and also what is most important for that individual. Financial
concerns are not typically addressed by clinicians, particularly when
attempting to teach patients and prepare them for transplant. This
particular concern could block the patient’s ability to process and
retain information about treatment and side effects. Priority con-
cerns shifted in both groups from global concerns at T1 to symptom
concerns at T2. This shift has implications for patient education.466
DEFINING THE SYMPTOM BURDEN OF CHRONIC GRAFT VERSUS HOST
DISEASE
Williams, L.A.1, Couriel, D.R.2, Neumann, J.L.3, Whisenant, M.S.4,
Galbizo, E.O.5, Cleeland, C.S.1. 1The University of Texas MDAnderson
Cancer Center, Houston, TX; 2Sarah Cannon Cancer Center and Ten-
nessee Oncology, Nashville, TN; 3The University of Texas MD Anderson
Cancer Center, Houston, TX; 4University of Utah, Salt Lake City, UT;
5The University of Texas MD Anderson Cancer Center, Houston, TX.
Significance: Chronic graft-versus-host disease (cGVHD) is an
autoimmune-like reaction occurring after allogeneic hematopoietic
stem cell transplantation (HSCT). cGVHD causes debilitating
symptoms for patients who have been cured of underlying malig-
nancies. Oncology nursing aims to decrease the burden of symp-
toms for patients and families. Problem and Purpose: There is
scant literature addressing the symptom burden of cGVHD. The
major barrier to good symptom management is inadequate assess-
ment. The specific aims of this study are to: 1) describe the symptom
experience of cGVHD; and 2) establish the content domain for an
instrument to measure the symptom burden of cGVHD. Theoret-
ical/Scientific Framework: The framework for this study is the
concept of symptom burden. Symptom burden is the combined im-
pact of all symptoms on one’s ability to function as one did prior to
onset of disease and therapy. Methods and Analysis: This was
a qualitative, cross-sectional study. The study sample included 20
adults with active cGVHD at a comprehensive cancer center in
the southern United States. Participants described their experience
of having cGVHD in single audiotaped dialogues. Using an explor-
atory descriptive method, the researcher analyzed transcripts of the
dialogues and developed themes of the cGVHD symptom experi-
ence. To ensure accuracy, identification of themes by the researcher
was reviewed and confirmed by 3 other researchers experienced in
qualitative analysis, oncology nursing, symptom assessment, and
HSCT. The themes were used to construct a unified description
of the symptom burden of cGVHD. Findings and Implications:
The symptom burden of cGVHD is multiple symptoms that inter-
fere with daily activities and require self-care management. Symp-
tom burden increases the longer the symptoms persist and the
more uncertain the occurrence of the symptoms and the outcome
